Can Malnutrition be Prevented in Patient With Colorectal Cancer Stage Dukes D? (ColErn)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00846313|
Recruitment Status : Withdrawn (Study was stopped due to lack of resources (clinical dietitians))
First Posted : February 18, 2009
Last Update Posted : April 8, 2015
|Condition or disease||Intervention/treatment||Phase|
|Colorectal Neoplasm||Other: Individual dietary counseling.||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||A Randomised Study of Dietary Counseling for Patients With Colorectal Cancer.|
|Study Start Date :||December 2003|
|Actual Primary Completion Date :||February 2009|
|Actual Study Completion Date :||February 2009|
Active Comparator: Dietary counseling
Patients receive dietary advice at an individual level and are offered contact with clinical dietitian every second week if necessary.
Other: Individual dietary counseling.
Dietary advice based on individual requirement and symptom burden. Dietary intervention may be dietary advice, energy rich foods and drinks, oral nutritional supplements, appetite stimulation with Megestrol Acetate, enteral or parenteral nutrition.
Other Name: Dietary intervention.
|No Intervention: Control|
- Body weight [ Time Frame: 2 year ]
- Body composition [ Time Frame: 2 year ]
- Quality of life [ Time Frame: 2 years ]
- Oncologic treatment [ Time Frame: 2 years ]
- Dietary intake [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00846313
|Principal Investigator:||Lene Thoresen, MSc||St. Olavs Hospital, NTNU|